Transcriptomic changes in invasive residual cancer after neoadjuvant chemotherapy in patients with triple-negative breast cancer

被引：0
|
作者：
Orozco, Javier [1 ]
Manughian-Peter, Ayla [1 ]
Gago, Francisco [2 ]
Chang, Grace [1 ]
Grumley, Janie [1 ]
Marzese, Diego [1 ]
机构：
[1] Providence St Johns Hlth Ctr, John Wayne Canc Inst, Santa Monica, CA USA
[2] Italian Hosp Mendoza, Mendoza, Argentina
来源：
ANNALS OF SURGICAL ONCOLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
581545
引用
收藏
页码：23 / 24
页数：2
相关论文
共 50 条
  • [21] BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Tanino, Hirokazu
    Kosaka, Yoshimasa
    Nishimiya, Hiroshi
    Tanaka, Youko
    Minatani, Naoko
    Kikuchi, Mariko
    Shida, Akiko
    Waraya, Mina
    Katoh, Hiroshi
    Enomoto, Takumo
    Sengoku, Norihiko
    Kajita, Sabine
    Hoffman, Robert M.
    Watanabe, Masahiko
    PLOS ONE, 2016, 11 (12):
  • [22] The response to neoadjuvant chemotherapy and prognosis of triple-negative breast cancer patients.
    Nakano, E.
    Hojo, T.
    Masumura, K.
    Kikuyama, M.
    Akashi, S.
    Kinoshita, T.
    CANCER RESEARCH, 2009, 69 (02) : 337S - 337S
  • [23] Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030
    Parsons, H. A.
    Blewett, T.
    Chu, X.
    Sridhar, S.
    Santos, K.
    Xiong, K.
    Abramson, V. G.
    Patel, A.
    Cheng, J.
    Brufsky, A.
    Rhoades, J.
    Force, J.
    Liu, R.
    Traina, T. A.
    Carey, L. A.
    Rimawi, M. F.
    Miller, K. D.
    Stearns, V.
    Specht, J.
    Falkson, C.
    Burstein, H. J.
    Wolff, A. C.
    Winer, E. P.
    Tayob, N.
    Krop, I. E.
    Markrigiorgos, G. M.
    Golub, T. R.
    Mayer, E. L.
    Adalsteinsson, V. A.
    ANNALS OF ONCOLOGY, 2023, 34 (10) : 899 - 906
  • [24] Residual cancer burden index and tumor-infiltrating lymphocyte subtypes in triple-negative breast cancer after neoadjuvant chemotherapy
    Pinard, Clemence
    Debled, Marc
    Ben Rejeb, Houda
    Velasco, Valerie
    Tunon de Lara, Christine
    Hoppe, Stephanie
    Richard, Elodie
    Brouste, Veronique
    Bonnefoi, Herve
    MacGrogan, Gaetan
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 179 (01) : 11 - 23
  • [25] Residual cancer burden index and tumor-infiltrating lymphocyte subtypes in triple-negative breast cancer after neoadjuvant chemotherapy
    Clémence Pinard
    Marc Debled
    Houda Ben Rejeb
    Valérie Velasco
    Christine Tunon de Lara
    Stéphanie Hoppe
    Elodie Richard
    Véronique Brouste
    Hervé Bonnefoi
    Gaëtan MacGrogan
    Breast Cancer Research and Treatment, 2020, 179 : 11 - 23
  • [26] Lymph node ratio as best prognostic factor in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy
    De la Cruz-Ku, Gabriel A.
    Chambergo-Michilot, Diego
    Valcarcel, Bryan
    Rebaza, Pamela
    Moller, Mecker
    Araujo, Jhajaira M.
    Enriquez, Daniel
    Morante, Zaida
    Razuri, Cesar
    Luque, Renato
    Saavedra, Antonella
    Eyzaguirre, Eduardo
    Lujan, Maria
    Noel, Naysha
    Pinto, Joseph
    Cotrina, Jose
    Gomez, Henry
    BREAST JOURNAL, 2020, 26 (09): : 1659 - 1666
  • [27] Genomic change in residual triple-negative breast cancers after neoadjuvant chemotherapy
    Aguilar-Mahecha, Adriana
    Przybytkowski, Ewa
    Lafleur, Josiane
    Lan, Cathy
    Legare, Stephanie
    Alirezaie, Najmeh
    Seguin, Carole
    Discepola, Federico
    Kovacina, Bojan
    Mihalcioiu, Catalin
    Robidoux, Andre
    Marcus, Elizabeth
    Roy, Josee Anne
    Pelmus, Manuela
    Aleynikova, Olga
    Nabavi, Sheida
    Majewski, Jacek
    Basik, Mark
    CANCER RESEARCH, 2015, 75
  • [28] The immune landscape of residual triple-negative breast cancers after neoadjuvant chemotherapy
    Gonzalez-Ericsson, Paula I.
    Sanchez, Violeta
    Salgado, Roberto
    Bordeaux, Jennifer
    Kim, Ju Y.
    Vaupel, Christine
    Gomez, Henry
    Sanders, Melinda E.
    Balko, Justin M.
    CANCER RESEARCH, 2020, 80 (04)
  • [29] Pathologic Response After Neoadjuvant Chemotherapy Predicts Locoregional Control in Patients With Triple-Negative Breast Cancer
    Gillespie, E.
    Chen, V. E.
    Murphy, J.
    Yashar, C. M.
    Lu, S. M.
    Einck, J. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S241 - S241
  • [30] The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
    Johnson, Kai Conrad Cecil
    Goldstein, Daniel
    Tharakan, Jasmin
    Quiroga, Dionisia
    Kassem, Mahmoud
    Grimm, Michael
    Miah, Abdul
    Vargo, Craig
    Berger, Michael
    Sudheendra, Preeti
    Pariser, Ashley
    Gatti-Mays, Margaret E. E.
    Williams, Nicole
    Stover, Daniel
    Sardesai, Sagar
    Wesolowski, Robert
    Ramaswamy, Bhuvaneswari
    Tozbikian, Gary
    Schnell, Patrick M. M.
    Cherian, Mathew A. A.
    ONCOLOGY AND THERAPY, 2023, 11 (03) : 361 - 374
12345